The Valley Desk

NCT03113422 · Interventional trial

Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy

Overall registry status Completed

Phase 2

Conditions Follicular Lymphoma, Non-Hodgkin's Lymphoma Follicular, Non-Hodgkin's Lymphoma, Adult High Grade

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov